Tymoszuk Piotr, Mag. PhD

University / Clinic:
Institute: Division of Medical Biochemistry, Biocenter
Research Area:

Email: piotr.tymoszuk@i-med.ac.at

Research Topic:

Selected publications:
  Schuler F, Baumgartner F, Klepsch-Pedit V, Chamson M, Müller-Holzner E, Watson C, Oh S, Hennighausen L, Tymoszuk P, Doppler W, Villunger A
The BH3-only protein BIM contributes to late-stage involution in the mouse mammary gland.
Cell Death Differ. 2015 Jun 5. doi: 10.1038/cdd.2015.61. [Epub ahead of print]

  Tymoszuk P, Evens H, Marzola V, Wachowicz K, Wasmer M, Datta S, Müller-Holzner E, Fiegl H, Böck G, van Rooijen N, Theurl I, Doppler W
In situ proliferation contributes to accumulation of tumor-associated macrophages in spontaneous mammary tumors.
Eur J Immunol. 2014 Aug;44(8):2247-62.

  Tymoszuk P, Charoentong P, Hackl H, Spilka R, Müller-Holzner E, Trajanoski Z, Obrist P, Revillion F, Peyrat J, Fiegl H, Doppler W
High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer.
BMC Cancer. 2014 Apr 12;14:257.

  Datta S, Parajuli N, Tymoszuk P, Ottina E, Parson W, Sgonc R, Villunger A, Doppler W
Replenishment of the B cell compartment after doxorubicin-induced hematopoietic toxicity is facilitated by STAT1.
J Leukoc Biol. 2014 Jun;95(6):853-66.

  Hannesdóttir L, Tymoszuk P, Parajuli N, Wasmer M, Philipp S, Daschil N, Datta S, Koller J, Tripp C, Stoitzner P, Müller-Holzner E, Wiegers G, Sexl V, Villunger A, Doppler W
Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response
Eur J Immunol. 2013 Jun 12

  Tymoszuk P, Doppler W
Impact of STAT1 and CD8+ T cells on the antineoplastic activity of lapatinib and doxorubicin against spontaneous mammary tumors.
Oncoimmunology. 2013 Dec 1;2(12):e26689.

  Hannesdóttir L, Daschil N, Philipp S, Tymoszuk P, Müller-Holzner E, Klima G, Verdorfer I, Doppler W
MMTV-neu mice deficient in STAT1 are susceptible to develop ovarian teratomas.
Int J Dev Biol. 2012;56(4):279-83.